Jaguar Health (NASDAQ:JAGX) Stock Crosses Above Fifty Day Moving Average – Here’s What Happened

Jaguar Health, Inc. (NASDAQ:JAGX) crossed above its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of $1.01 and traded as high as $1.03. Jaguar Health shares last traded at $1.01, with a volume of 224,346 shares.

Analyst Upgrades and Downgrades

Separately, StockNews.com upgraded shares of Jaguar Health from a “sell” rating to a “hold” rating in a report on Friday, September 13th.

Jaguar Health Price Performance

The business has a 50-day moving average of $1.01 and a 200 day moving average of $1.61. The company has a debt-to-equity ratio of 1.65, a current ratio of 1.84 and a quick ratio of 1.36.

Institutional Trading of Jaguar Health

An institutional investor recently bought a new position in Jaguar Health stock. Perritt Capital Management Inc acquired a new position in shares of Jaguar Health, Inc. (NASDAQ:JAGX) in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 25,000 shares of the biotechnology company’s stock, valued at approximately $90,000. Perritt Capital Management Inc owned approximately 0.51% of Jaguar Health as of its most recent filing with the Securities and Exchange Commission. 12.04% of the stock is owned by institutional investors.

Jaguar Health Company Profile

Jaguar Health, Inc, a commercial stage pharmaceuticals company, focuses on developing plant-based prescription medicines for people and animals with gastrointestinal distress, specifically chronic and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It focuses on developing and commercializing prescription and non-prescription products for companion and production animals; and human products.